financetom
Business
financetom
/
Business
/
Soccer-Newcastle secure Champions League spot on final day despite Everton defeat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Soccer-Newcastle secure Champions League spot on final day despite Everton defeat
May 26, 2025 1:45 PM

NEWCASTLE, England, May 25 (Reuters) - Newcastle United squeezed into the Champions League places despite losing 1-0 to Everton at home in their final game of the Premier League season on Sunday, thanks to Manchester United's ( MANU ) 2-0 home win over Aston Villa.

The Magpies, who ended a 70-year domestic trophy drought by beating Liverpool to win the League Cup earlier in the season, ended up in fifth place on 66 points, edging out Villa on goal difference.

Newcastle dominated throughout but were undone by poor finishing and sloppy passing and they were punished for giving away the ball in the centre of the pitch in the 65th minute, with Vitaliy Mykoloenko crossing for Carlos Alcaraz to score with a brilliant header.

The home side poured forward late in the second half as they sought to salvage some pride with an equaliser but Everton were in no mood to accommodate them and defended doggedly to the bitter end, finishing their season in 13th place on 48 points.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tivic Health Systems Gets 3 New Patents in US, Europe
Tivic Health Systems Gets 3 New Patents in US, Europe
Jul 23, 2024
10:31 AM EDT, 07/23/2024 (MT Newswires) -- Tivic Health Systems ( TIVC ) said Tuesday it has received three new patents in the US and Europe. The company said it has received the patents Sinus Treatment Device With Adaptive Circuit from the European Patent Office and Adaptive Trigger for a Microcurrent Stimulation Device from Europe and the US Patent and...
Novo Nordisk gets UK approval for using weight-loss drug to reduce heart risks
Novo Nordisk gets UK approval for using weight-loss drug to reduce heart risks
Jul 23, 2024
July 23 (Reuters) - Novo Nordisk's weight-loss drug Wegovy has secured the UK regulator's approval for its use to reduce the risk of overweight and obese adults suffering serious heart problems or strokes, the agency said on Tuesday. (Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur) ...
Ainos Enrolls First Subject in Taiwanese Trial for VELDONA-Based Feline FCGS Treatment
Ainos Enrolls First Subject in Taiwanese Trial for VELDONA-Based Feline FCGS Treatment
Jul 23, 2024
10:31 AM EDT, 07/23/2024 (MT Newswires) -- Ainos (AIMD) said Tuesday it enrolled the first subject in its Taiwanese clinical trial of a VELDONA-based animal drug for treating feline chronic gingivostomatitis. The first subject is scheduled to receive the dose on Friday, the company said. FCGS is a severe and painful chronic oral disease in cats, marked by inflammation or...
Johnson Controls To Boost Profit Margins With $8.1B Bosch Deal
Johnson Controls To Boost Profit Margins With $8.1B Bosch Deal
Jul 23, 2024
Johnson Controls International ( JCI ) plc shares are trading higher after the company agreed to sell its Residential and Light Commercial (R&LC) HVAC business to the Bosch Group. The total transaction is valued at $8.1 billion, with Johnson Controls’ share of around $6.7 billion. The transaction includes $4.6 billion for its North America Ducted business (16.7x fiscal 2023 EBITDA) and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved